CNP
44
-6
NI
70
-3
HOG
35
2
UPS
48
-2
MCK
73
-2
TAP
60
-4
DOV
69
-4
DAL
88
-2
FAST
61
-3
XRX
37
3
GS
69
-6
PCAR
62
-2
HSY
38
-5
PEP
50
2
DE
39
3
GE
65
-6
OXY
52
-3
GT
60
-2
LH
46
-4
TSN
50
2
CNP
44
-6
NI
70
-3
HOG
35
2
UPS
48
-2
MCK
73
-2
TAP
60
-4
DOV
69
-4
DAL
88
-2
FAST
61
-3
XRX
37
3
GS
69
-6
PCAR
62
-2
HSY
38
-5
PEP
50
2
DE
39
3
GE
65
-6
OXY
52
-3
GT
60
-2
LH
46
-4
TSN
50
2
Financhill
Back

ProPhase Labs 10K Form

Sell
22

PRPH
ProPhase Labs

Last Price:
0.74
Seasonality Move:
18.16%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PRPH News And Ratings

See the #1 stock for the next 7 days that we like better than PRPH

PRPH Financial Statistics

Sales & Book Value

Annual Sales: $44.38M
Cash Flow: $-4.84M
Price / Cash Flow: 0
Annual Sales: $2.31
Price / Book: 0.33

Profitability

EPS (TTM): -1.49000
Net Income (TTM): $-26.31M
Gross Margin: $16.24M
Return on Equity: -51.79%
Return on Assets: -28.7%

ProPhase Labs Earnings Forecast

Key ProPhase Labs Financial Ratios

  • The Gross Profit Margin over the past 27 years for PRPH is 36.59%.
  • The Selling, General & Administrative Expenses for PRPH have been equal to 77.74% of Gross Profit Margin.
  • The Research & Development expenses have been 3.19% of Revenue.
  • The Interest Expense is -7.60% of Operating Income.
  • The Net Earning history of PRPH is -37.81% of Total Revenues.
  • Per Share Earnings over the last 28 years have been positive in 15 years.

ProPhase Labs Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: PRPH
CUSIP: 74345W
Website: prophaselabs.com

Debt

Debt-to-Equity Ratio: 0.31
Current Ratio: 1.58
Quick Ratio: 1.24

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PRPH Technical Analysis vs Fundamental Analysis

Sell
22
ProPhase Labs (PRPH) is a Sell

Is ProPhase Labs a Buy or a Sell?

  • ProPhase Labs stock is rated a Sell
    The current ProPhase Labs [PRPH] share price is $0.75. The Score for PRPH is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.